Oral Vancomycin is NOT Indicated for Gastritis
Oral vancomycin should not be used to treat gastritis. The FDA-approved indications for oral vancomycin are strictly limited to Clostridioides difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) 1. Gastritis is explicitly excluded from these indications.
Why Oral Vancomycin Doesn't Work for Gastritis
The FDA label clearly states: "Orally administered Vancomycin Hydrochloride Capsules are not effective for other types of infections" 1. This is a critical limitation because:
- Oral vancomycin is not systemically absorbed in patients with normal intestinal mucosa 1
- It works only through direct contact with bacteria in the gastrointestinal lumen
- Gastritis involves inflammation of the gastric mucosa, not a luminal infection treatable by oral vancomycin
What Actually Treats Gastritis
According to current evidence, appropriate pharmacological treatment for gastritis includes 2:
- Proton pump inhibitors (PPIs) or potassium-competitive acid blockers (P-CABs) for acid suppression
- H2-receptor antagonists (H2RAs) for reducing gastric acid secretion
- Mucoprotective agents to enhance gastric mucosal protection
- H. pylori eradication therapy if infection is present (which does NOT include oral vancomycin)
The Single Exception: Phlegmonous Gastritis
There is one case report of phlegmonous gastritis (a rare, severe bacterial infection of the gastric wall) treated with vancomycin for multidrug-resistant streptococcus 3. However, this represents an extremely rare, life-threatening condition—not typical gastritis—and the vancomycin was used off-label for a specific resistant organism identified on culture.
Common Pitfall to Avoid
Do not confuse oral vancomycin's role in treating C. difficile colitis with any indication for gastritis. The fact that both conditions involve the GI tract does not make vancomycin appropriate for gastritis. The drug must be given for proven or strongly suspected susceptible bacterial infections per FDA guidance 1.
If a patient has gastritis symptoms, pursue standard gastritis treatment with PPIs, H2RAs, or mucoprotective agents—not oral vancomycin.